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Abstract
Background: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these
symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated
with depression and anxiety, since they can be responsible for premature morbidity, mortality, risk of developing
comorbidities, complications, suffering of patients, as well as escalation of costs. We studied the frequency of depression
and anxiety in Mexican outpatients with type 2 diabetes and identified the risk factors for depression and anxiety.
Methods and Findings: We performed a study in 820 patients with type 2 diabetes. The prevalence of depression and
anxiety was estimated using the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale, respectively. We
calculated the proportions for depression and anxiety and, after adjusting for confounding variables, we performed
multivariate analysis using multiple logistic regressions to evaluate the combined effect of the various factors associated
with anxiety and depression among persons with type 2 diabetes. The rates for depression and anxiety were 48.27% (95%
CI: 44.48–52.06) and 55.10% (95% CI: 51.44–58.93), respectively. Occupation and complications in diabetes were the factors
associated with anxiety, whereas glucose level and complications in diabetes were associated with depression.
Complications in diabetes was a factor common to depression and anxiety (p,0.0001; OR 1.79, 95% CI 1.29–2.4).
Conclusions: Our findings demonstrate that a large proportion of diabetic patients present depression and/or anxiety. We
also identified a significant association between complications in diabetes with depression and anxiety. Interventions are
necessary to hinder the appearance of complications in diabetes and in consequence prevent depression and anxiety.
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Introduction
The global prevalence of diabetes is continuously rising. It is
estimated that almost 285 million persons are currently suffering
from diabetes worldwide, and the number is expected to rise to
438 million by the year 2030; more than 70% of these individuals
reside in developing countries [1]. The literature reports that
patients with diabetes are almost twice as likely to suffer from
depression and anxiety as the general population [2,3]. Recently, a
biologic mechanism has been suggested that associates both
depression and diabetes with deregulated and overactive hypo-
thalamic-pituitary-adrenal axis activity [4,5]. Depression as a
chronic psychological stress is associated with sub-clinical hyper-
cortisolism secondary to the activation of the hypothalamic-
pituitary-adrenal axis [5]. Cortisol is a counterregulatory hormone
and its prolonged exposure induces visceral adiposity, insulin
resistance, dyslipidemia, and hypertension (all metabolic precur-
sors to type 2 diabetes). This hormone stimulates the sympathetic
nervous system, increases inflammatory and platelet aggregation
responses, and decreases insulin sensitivity [1,5,6,7]. This suggests
that increased cortisol in diabetes can be considered a risk factor
for the development and presence of depression and anxiety.
These symptoms can lead to consequences in the life of patients,
given that emotional problems may influence patient adherence to
lifestyle and treatment recommendations. As a result, decreased
quality of life, impaired self-care behavior, and poorer glycemic
control may ensue and contribute to increase health care costs
[2,8].
Depression is associated with a wide range of negative
consequences, including significant worsening of comorbid med-
ical conditions, high mortality risk related to suicide, and
socioeconomic burden resulting from functional impairment
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associated with premature morbidity and mortality, and when
these conditions coexist, the risk for developing comorbidities,
complications, suffering of patients, and associated costs escalates
[11,12]. Therefore, it is relevant to establish the diagnoses of
depression and anxiety in the diabetic patient. The presence of
undiagnosed anxiety and depression among persons with this
condition is a cause of concern since these symptoms hinder the
initiation of treatment and allows frustration to build up in
patients, thereby contributing to poor clinical outcomes [1].
In Mexico, diabetes is a common disorder. The prevalence in
the general population is 7% [13]; 6.5% in males and 7.3% in
females. The frequency of this disease is on the rise. In 1993, its
prevalence was 4.6%; nevertheless, in the year 2000, it increased
to 5.8%, and 7% in 2006 [13]. Among the Mexican general
population, anxiety exhibits a frequency of 14.3%, whereas for
depression it amounts to 9.1% [14]. These frequencies are similar
to the rates observed in the United States [15]. However, several
reports in Mexico have shown that the prevalence of depression in
diabetic patients can be 46%, 48.3% and 63% [16,17,18]. In
contrast, there are no reports in the literature evaluating anxiety in
the Mexican population.
Various studies to assess anxiety and depression and their
associated factors among diabetic patients have been undertaken
in many developed countries. For example, a sectional study in
the United Kingdom found that almost one-third of diabetic
persons suffer from anxiety and one-fourth from depression.
This outcome is in agreement with the results in other similar
studies [1,19,20,21,22]. However, only three studies have
reported an association between depression and diabetes in
the Mexican population [16,17,18], with the concomitant
limitation of having been carried out in small samples. Hence,
in this work, we determined the frequency of depression and
anxiety in outpatients with type 2 diabetes in the southeastern
part of Mexico. This study also provides socio-epidemiologic
findings of the participants, as well as risk factors for depression
and anxiety underlying this condition.
Results
Prevalence of Anxiety and Depression
From 827 participants only 704 that complied with the inclusion
criteria were included. From this sample, 48.27% (95% CI: 44.48–
52.06) were positive for depression and 55.10% (95% CI: 51.44–
58.93) for anxiety.
Descriptive Characteristics
In this sample, the larger group was formed of females (55.8%).
Most of them were married (71.4%) and mainly housewives
(39.0%). The socio-demographic characteristics of the participants
are summarized in Table 1. Mean age was 47.39612.79 with a
range of 18–79 years old. The mean level of education was
8.8164.91 years. Thirty-eight patients did not receive formal
education or were illiterate. The mean body mass index was
28.6365.49 with a range of 17–47. The average glucose level was
175.46674.37 mg/dl, with a range of 70–500 mg/dl. The mean
systolic BP was 120.00613.14 (range 90–180); the corresponding
average diastolic BP was 80.14610.84 (range 60–130). When we
analyzed anxiety the average score was 17.97611.39 (range 1–39),
whereas the mean score for depression was 18.58611.06, with a
range of 1–49.
Association of Dependent Variables with Depression and
Anxiety
Table 2 summarizes the results of univariate and multivariate
analyses for associations with anxiety. The factors that showed a
significant association with anxiety were occupation and presence
of complications. On the other hand, the factors significantly
associated with depression were glucose level and presence of
complications (see Table 3).
Multivariate Analysis
Finally, we looked for an association of independent factors with
anxiety and depression. As a result, we encountered that patients
with a history of complications with diabetes were significantly
associated with anxiety (p,0.0001; OR 1.79, 95% CI 1.29–2.4).
When this value was adjusted for confounding variables, the result
was similar (AOR 1.74, 95% CI 1.25–2.41). Likewise, the factors
housewife (AOR 1.52, 95% CI 1.01–2.28), student (AOR 2.34,
95% CI 1.14–4.80) and half-time employee (AOR 1.69, 95% CI
1.08–2.66) presented associations.
Table 1. Socio-epidemiologic characteristics and gender
differences of patients with type 2 diabetes.
Characteristics Number Percent
Gender Male 310 44.2
Female 392 55.8
Marital status Married 501 71.4
Single 100 14.2
Widowed 68 9.7
Separated/divorced 33 4.7
Occupation Unemployed 54 7.7
Housewife 274 39.0
Student 41 5.8
Full-time job 142 20.2
Half-time job 191 27.2
Age (in years) Up to 50 410 41.7
.50 292 58.3
Education Up to 6 years of
schooling
300 42.7
.6 years of schooling 402 57.3
Body mass index Up to 25 239 34.0
.25 463 66.0
Glucose level (mg/dl) Up to 120 131 18.6
.120 572 81.4
Use of substances Yes 325 46.3
No 378 53.7
Complications Yes 260 36.9
No 443 63.1
Anxiety With anxiety 388 52.9
Without anxiety 314 47.1
Depression With depression 335 47.7
Without depression 368 52.3
doi:10.1371/journal.pone.0036887.t001
Depression and Diabetes
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We estimated the prevalence of depression and anxiety in a type
2 diabetic population in the state of Tabasco in southern Mexico.
This study also showed that glucose levels and complications with
diabetes were significantly associated with depression; the factors
to have or not have occupation and complications in diabetes were
associated with anxiety.
It is important to acknowledge the prevalence of depression
and/or anxiety in diabetic patients since the development of co-
morbid anxiety and/or depression in people with this condition
not only leads to increase disease severity, complications, work
disability, and poor quality of life, but is also associated with
increased used of medical services and substantially higher health
care costs [1,11,12,23]. Currently, to recognize depression in
diabetic patients is not a general practice.
In this study, the prevalence of depression was estimated at
48.27%. In the literature there are three studies on the Mexican
population that have analyzed this prevalence [16,17,18]. And
although these studies were carried out in different regions of
Mexico, they exhibited similar frequencies, viz., 46%, 48.3% and
63%. However, sample sizes were small (n=79,186 and 450,
respectively). In the present study, sample size was increased to
704 diabetic patients. In addition, we analyzed the frequency of
anxiety in these patients. To our knowledge, this is the first study
analyzing both depression and anxiety in the Mexican population.
Frequently, a higher prevalence of depression has been reported in
developed countries [24,25,26]. However, we found a similar
prevalence to the one reported in those studies. In fact, recent
studies have shown a similar prevalence in under-developed
countries [1,27].
The frequency of anxiety in our study was 55.10%. In the
literature, it has been frequently observed that anxiety has more
prevalence than depression. Besides, a higher prevalence of
anxiety is present in people suffering from chronic diseases
[19,28,29]. In the Mexican population, depression causes on
average 25.51 days of disability leaves of absence and anxiety 9.53
days on average [30]. Hence, alternative mechanisms are
necessary for the prevention of depression and anxiety in diabetic
patients.
We observed that the development of complications in diabetes
is a common factor associated with depression and anxiety; this is
consistent with the results in other studies reporting an association
with duration of diabetes [1,31,32]. In this respect, the duration of
diabetes is associated with the development of depression.
Increased duration of the disease is known to significantly increase
the risk for developing diabetic complications and health care
expenditures, as a result such patients are more prone to develop
psychological illnesses.
Some limitations can be identified in this study. The patients
with diabetes were only analyzed once and not at different times
within the duration of the study. The second limitation is that the
results were similar to studies using a self-report instrument to
measure depression and anxiety. In this case, dependent and
Table 2. Association between clinical characteristics and anxiety in patients with type 2 diabetes.
With
Anxiety
Without
Anxiety p-value OR (95% CI) p-value AOR (95% CI)*
Gender Male 165 145 0.33 0.86 (0.63–1.16) 0.17 1.25 (0.90–1.75)
Female 223 169
Marital status Married 274 227 0.77 0.70 1.03 (0.86–1.23)
Single 60 40
Widowed 36 32
Separated/divorced 13 15
Occupation Unemployed 32 22 0.04 0.14 0.91 (0.81–1.03)
Housewife 157 117
Student 26 15
Full-time job 85 57
Half-time job 88 103
Age (in years) Up to 50 230 180 0.56 1.09 (0.80–1.97) 0.55 0.91 (0.67–1.23)
.50 158 135
Education Up to 6 years of schooling 169 219 0.78 1.04 (0.77–1.40) 0.16 1.25 (0.91–1.71)
.6 years of schooling 134 181
Body mass index Up to 25 131 108 0.88 097 (0.71–1.33) 0.23 1.19 (0.88–1.61)
.25 257 207
Glucose level (mg/dl) Up to 120 67 64 0.30 0.81 (0.55–1.19) 0.03 1.44 (1.03–2.01)
.120 321 251
Use of substances Yes 187 138 0.24 1.19 (0.88–1.60) 0.18 0.80 (0.58–1.11)
No 201 177
Complications yes 167 93 0.0001 1.80 (1.31–2.47) 0.003 0.62 (0.45–0.85)
No 221 222
*Logistic regression model adjusted for all variables in the table.
CI: confidence interval; OR: odds ratio; AOR, adjusted odds ratio.
doi:10.1371/journal.pone.0036887.t002
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dent biases and measurement errors. Third, we did not utilize a
scale for diagnosing depression in the general population; our
main interest was to identify the presence of depression and
anxiety symptoms in diabetic patients. Fourth, this is not a random
sample, and it might not be epidemiologically valid, however, it
provides an estimation of the prevalence of depression and anxiety
in patients with type 2 diabetes in Tabasco, Mexico. Hence,
caution must be taken when generalizing these results to the entire
Mexican population.
In conclusion, this study shows a high prevalence of depression
and anxiety in a large sample of the Mexican population suffering
from diabetes. Besides, the development of complications in
diabetes was the principal factor associated with depression and
anxiety in these patients. Therefore, we suggest that it is necessary
to test diabetic patients for depression and anxiety using
psychiatric diagnosis to prevent the appearance of these symp-
toms. Finally, more comprehensive studies are necessary to
determine conclusively the pathophysiological mechanisms present
in this disease.
Methods
A total of 820 outpatients with type 2 diabetes were enrolled in
this study. Recruitment took place from January 2011 to
September 2011. This is a multi-center study that included the
following places: 1) Outpatient service of the Hospital General de
Comalcalco in the state of Tabasco, Me ´xico, 2) the clinical
laboratory ‘‘Centro de Investigacio ´n Geno ´mica’’ (Center for
Genomic Research) in Comalcalco, Tabasco, Me ´xico, and c)
Universidad Jua ´rez Auto ´noma de Tabasco (UJAT), specifically the
Divisio ´n Acade ´mica Multidisciplinaria de Comalcalco (DAMC) in
Tabasco, Me ´xico. Patients were not chosen at random, rather they
were recruited from the external consultation of the hospital or
from relatives of students from the Faculty of Medicine.
Comalcalco is a city in Tabasco with a population of 200 000
inhabitants.
Ethics Statement
All subjects signed an informed consent to participate in the
study after they were given a verbal and written explanation of the
research objectives; they did not receive any economical remu-
neration. Only Mexican subjects descending from Mexican
parents and grandparents participated in this study. This study
complied with the principles convened in the Helsinki Declaration.
In addition, this study was approved by the DAMC-UJAT Ethics
and Research Committee (P.O.A. 20111282).
Data Collection
Persons with type 2 diabetes, previously diagnosed by a
physician, were included in this study. Age range was 18–80
years old. Personal and familiar history of diabetes was collected
using structured interviews designed specifically for this study. All
Table 3. Association between clinical characteristics and depression in patients with type 2 diabetes.
With
depression
Without
depression p-value OR (95% CI) p-value AOR (95% CI)*
Gender Male 139 171 0.17 0.81 (0.60–1.09) 0.07 1.36 (0.96–1.93)
Female 196 196
Marital status Married 234 267 0.56 0.43 1.07 (0.89–1.28)
Single 51 49
Widowed 31 37
Separated/divorced 19 14
Occupation Unemployed 21 33 0.25 0.83 1.01 (0.89–1.14)
Housewife 135 139
Student 21 20
Full-time job 75 67
Half-time job 21 33
Age (in years) Up to 50 195 215 0.95 0.99 (0.73–1.33) 0.63 0.91 (0.65–1.29)
.50 140 153
Education Up to 6 years of schooling 146 157 0.80 1.03 (0.76–1.40) 0.78 1.04 (0.74–1.47)
.6 years of schooling 189 211
Body mass index Up to 25 122 117 0.19 1.22 (0.89–1.68) 0.29 0.84 (0.61–1.16)
.25 213 251
Glucose level (mg/dl) Up to 120 49 82 0.009 0.59 (0.40–0.87) 0.021 1.60 (1.07–2.38)
.120 286 286
Use of substances Yes 164 161 0.16 1.23 (0.91–1.06) 0.08 0.74 (0.53–1.03)
No 171 207
Complications yes 140 120 0.01 1.40 (1.06–1.97) 0.67 0.67 (0.48–0.93)
No 195 243
*Logistic regression model adjusted for all variables in the table.
CI: confidence interval; OR: odds ratio; AOR, adjusted odds ratio.
doi:10.1371/journal.pone.0036887.t003
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or nurses participating in this study. Both psychologists and nurses
hold at least a Master’s degree.
Anthropometric Measurements
In this study the following parameters were collected: height,
weight and blood pressure. Height was measured using stadi-
ometers having 1 mm precision and body weight (Kg) using a
digital scale with 100-g precision.
Overweight and obesity were classified according to interna-
tional obesity task force criteria, based on body mass index (BMI)
measurements, with cutoff values based on BMI. Cutoff points are
a projection of the criteria proposed by WHO for diagnosing
overweight (BMI between 25 and 29.9) and obesity (BMI of 30 or
more).
To determine arterial blood pressure (BP) we used a calibrated
sphygmomanometer, aneroid type, and a stethoscope. Patient was
asked to remain seated for ten minutes before the pressure was
taken. All the measurements were carried out on left and right
arms in compliance with the Mexican official norm NOM-030-
SSA2-1999, which refers to Prevention, Treatment and Control of
Arterial Hypertension. Measurements were taken by trained and
standardized personnel using standard procedures.
Definition of Diabetes
This study included only patients previously diagnosed diabetes
mellitus by a physician. The presence of diabetes was defined as a
fasting plasma glucose value $7.0 mmol/l (126 mg/dl); individ-
uals with unknown or pre-diabetes status were not included in this
study.
Definition of Complications in Diabetes
Complications in diabetes were considered when patients
presented retinopathy, cardiomyopathies, nephropathies, and
neuropathies associated with diabetes mellitus.
Definition of Depression and Anxiety
We evaluated depression and anxiety with the Hamilton
Depression Rating Scale (Ham-D) and the Hamilton Anxiety
Rating Scale (Ham-A), respectively [33]. Both scales are
commonly used at the health service of the Hospital de
Comalcalco in Tabasco.
Ham-D is the most commonly used observer-rated depressive
symptom rating scale. Although the original scale has 21 items, we
used a 17-item reduced version. Nine items with quantifiable
severity were ranked on a scale 0–4 and those measuring
symptoms that are difficult to assess reliably were ranked on a
scale 0–2 (8 items) [34]. The range of the 17-item scale was 0–50,
with 14 considered to be the cutoff point of this scale; higher scores
indicate more severe depression.
The Ham-A is a 14-item clinician-rated instrument designed to
assess and quantify the severity of anxiety. Each item is rated on a
five-point Likert-type scale ranging from 0 to 4. Although the scale
assesses a broad range of symptoms, it is most frequently used to
assess the severity of general anxiety disorder [35,36]. Ham-A is
comprised of psychic and somatic subscales. The psychic subscale
(items 1–6 and 14) evaluates the more subjective cognitive and
affective complaints of anxiety (e.g., anxious mood, tension, fears,
difficulty concentrating); it is particularly useful in assessing the
severity of general anxiety disorder. The somatic component
(items 7–13) emphasizes features of general anxiety disorder such
as autonomic arousal, as well as respiratory, gastrointestinal and
cardiovascular symptoms.
Statistical Analysis
All data are presented as numbers (in percentage) for categorical
variables. Ratios were calculated for the variables of interest.
Descriptive statistics was used to characterize the sample. The chi-
squared test was conducted to compare variables. Multivariate
analysis using multiple logistic regressions was carried out to
evaluate the combined effect of several factors associated with
anxiety and depression among persons with type 2 diabetes after
adjusting for confounding variables. Results are presented as
adjusted odds ratios (AOR) with 95% CI, which express the
magnitude of the effect of each category on the outcome relative to
the reference category.
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